WKN: | 890167 |
ISIN: | US0126531013 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Chemie |
aktueller Kurs: |
89,33 EUR
|
Veränderung: |
4,94 EUR
|
Veränderung in %: |
5,85 %
|
Weshalb die Albemarle-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 14. Januar 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2009 | 13,66 | 25,79 | 88,80% |
2 | 2020 | 64,15 | 119,00 | 85,50% |
3 | 2021 | 119,00 | 205,10 | 72,35% |
4 | 2006 | 16,25 | 27,29 | 67,94% |
5 | 2010 | 25,79 | 42,46 | 64,64% |
6 | 2016 | 51,82 | 82,55 | 59,30% |
7 | 2017 | 82,55 | 107,50 | 30,22% |
8 | 2012 | 39,67 | 46,37 | 16,89% |
9 | 2005 | 14,39 | 16,25 | 12,93% |
10 | 2004 | 13,25 | 14,39 | 8,60% |
11 | 2014 | 46,16 | 49,88 | 8,06% |
12 | 2015 | 49,88 | 51,82 | 3,89% |
13 | 2007 | 27,29 | 28,19 | 3,30% |
14 | 2002 | 13,25 | 13,25 | 0,00% |
15 | 2003 | 13,25 | 13,25 | 0,00% |
16 | 2025 | 84,30 | 84,15 | -0,18% |
17 | 2013 | 46,37 | 46,16 | -0,45% |
18 | 2022 | 205,10 | 202,85 | -1,10% |
19 | 2019 | 67,65 | 64,15 | -5,17% |
20 | 2011 | 42,46 | 39,67 | -6,57% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2008 | 28,19 | 13,66 | -51,54% |
2 | 2024 | 135,16 | 84,30 | -37,63% |
3 | 2018 | 107,50 | 67,65 | -37,07% |
4 | 2023 | 202,85 | 135,16 | -33,37% |
5 | 2011 | 42,46 | 39,67 | -6,57% |
6 | 2019 | 67,65 | 64,15 | -5,17% |
7 | 2022 | 205,10 | 202,85 | -1,10% |
8 | 2013 | 46,37 | 46,16 | -0,45% |
9 | 2025 | 84,30 | 84,15 | -0,18% |
10 | 2003 | 13,25 | 13,25 | 0,00% |
11 | 2002 | 13,25 | 13,25 | 0,00% |
12 | 2007 | 27,29 | 28,19 | 3,30% |
13 | 2015 | 49,88 | 51,82 | 3,89% |
14 | 2014 | 46,16 | 49,88 | 8,06% |
15 | 2004 | 13,25 | 14,39 | 8,60% |
16 | 2005 | 14,39 | 16,25 | 12,93% |
17 | 2012 | 39,67 | 46,37 | 16,89% |
18 | 2017 | 82,55 | 107,50 | 30,22% |
19 | 2016 | 51,82 | 82,55 | 59,30% |
20 | 2010 | 25,79 | 42,46 | 64,64% |